GTC Biotherapeutics (fka GTCB)

[Lewis R Goudy]

Speaking of listing, our minimum closing bid compliance
deadline came and went over three months ago. We didn't
RS or address the market cap deficiency by dropping to
the second tier. There is a moratorium on delisting action
by Nasdaq (extending our deadline) but that just happened.

Point is, Nasdaq has been remarkably accommodating. Under
the circumstances I can't claim they remain so, but that they
cut us as much slack as they already have suggests that they
have seen something that we have not (like a plan).